HCP
56
-8
MRO
50
4
RCL
83
-2
DFS
64
2
KLAC
38
-6
ICE
59
-3
DD
53
-6
ETR
65
2
EW
32
3
GOOGL
48
-5
IR
63
-3
HAL
48
-3
STX
45
-4
GME
66
-5
CPB
22
-5
PFE
14
-7
DTE
43
5
KMX
61
-3
OI
42
-3
AMGN
42
-4
HCP
56
-8
MRO
50
4
RCL
83
-2
DFS
64
2
KLAC
38
-6
ICE
59
-3
DD
53
-6
ETR
65
2
EW
32
3
GOOGL
48
-5
IR
63
-3
HAL
48
-3
STX
45
-4
GME
66
-5
CPB
22
-5
PFE
14
-7
DTE
43
5
KMX
61
-3
OI
42
-3
AMGN
42
-4
Financhill
Back

Structure Therapeutics Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
18

GPCR
Structure Therapeutics

Last Price:
34.18
Seasonality Move:
-11.15%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
18
Structure Therapeutics (GPCR) is a Sell

Is Structure Therapeutics a Buy, Sell or Hold?

  • The current Structure Therapeutics [GPCR] share price is $34.17. The Score for GPCR is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • GPCR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GPCR Stock Price Chart

What is Structure Therapeutics's stock price today?

  • The Structure Therapeutics share price today is $34.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.81 Sell
Relative Strength Index (14 RSI): 35.81 Sell
Chaikin Money Flow: -937317 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.72 - 39.7) Sell
Bollinger Bands (100): (36.27 - 41.27) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.32 Sell
20-day SMA: 38.28 Sell
50-day SMA: 39.33 Sell
200-day SMA: 40.08 Sell
8-day EMA: 37.04 Sell
20-day EMA: 38.08 Sell
50-day EMA: 38.82 Sell
200-day EMA: 39.53 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Structure Therapeutics Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.15 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Structure Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):